Searched for
GENNOVA
Gennova Bio joins CEPI to develop vax against Nipah virusGennova Biopharmaceuticals, in partnership with CEPI, will advance the development of a self-amplifying mRNA vaccine against Nipah virus wi...- Emcure and its subsidiary Gennova settle legal dispute with HDT Bio over mRNA technologyEmcure Pharmaceuticals and its subsidiary Gennova have resolved all legal disputes with US-based HDT Bio Corp. The parties have entered int...
- CEPI to fund Gennova's self amplifying mRNA vaccine against Disease XThe Coalition for Epidemic Preparedness Innovations (CEPI) and Gennova Biopharmaceuticals have announced a new funding agreement to develop...
- Drug panel may review Gennova's mRNA Omicron booster vaccinePune-based Gennova Biopharmaceuticals had submitted data to the drug regulator this month, amid an increase in the number of Covid-19 cases...
- Gennova Biopharma seeks DCGI nod for its Omicron boosterGennova has developed an Omicron specific vaccine GEMCOVAC-OM which has been assessed for its safety and immunogenicity when administered a...
- Centre to work on pricing to include Gennova mRNA shot in vaccine driveIndia's drug regulator has approved Gennova's mRNA vaccine for restricted use in emergency situations in adults. Samit Mehta, chief operati...
- Gennova in talks with govt to price mRNA vaccine competitivelySince Gennova has the manufacturing-at-risk approval, it has already produced 7 million doses that have been released not only by the compa...
- Panel recommends emergency use nod to India's 1st mRNA vaccineThe Subject Expert Committee recommended the authorisation in a meeting held on Friday. The vaccine is developed by Pune-based Gennova Biop...
- Gennova's mRNA-based vaccine to be delayedGennova had last month submitted interim data on India's first indigenously developed mRNA Covid vaccine to the drug regulator. The Central...
- Gennova Biopharma submits final vaccine trial data to regulatorPune-based Gennova is developing the country's first indigenously developed mRNA vaccine for Covid-19. The subject expert committee under t...
- Gennova to finish Phase 2 & 3 trials of its mRNA jab by January 2022The company had submitted the interim Phase-1 clinical trial data to CDSCO, where it tested for safety and immunogenicity.
- Pune-based Gennova to use SII's Covishield vaccine as the comparatorTo assess the immunogenicity of the mRNA vaccine, Gennova will have to use Covishield — an existing vaccine — as a comparator, as the regul...
- Gennova Biopharmaceuticals granted conditional permission for human clinical trial of its COVID-19 vaccineThe recommendations of the Subject Expert Committee (SEC) on COVID-19, which deliberated upon the proposal submitted by the firm for grant ...
- Gennova Biopharma to start mRNA vaccine trials by the year's end; results likely in March '21The trial results are likely to come in by March 2021, Sanjay Singh, CEO of Pune-based Gennova, told ET. There is a possibility that India ...
- Boehringer Ingelheim hid key info in petition, says GennovaGennova’s stroke medicine — tenecteplase — was approved by an expert committee of the Central Drugs Standard Control Organisation (CDSCO) i...
- Gennova moves application to dismiss Boehringer’s case on stroke medicineGennova alleges that Boehringer did not disclose a PIL still pending with another bench at the court on the same objections when it filed i...
- Battle over stroke medicine between Boehringer and Gennova heats up at courtGennova didn’t follow the ethical guidelines issued by the Indian Council of Medical Research (ICMR) while designing its clinical study for...
- Delhi High Court defers order blocking Gennova’s stroke drugGennova's drug can't be approved as a biosimilar of tenecteplase as the original drug isn't prescribed for strokes, argued P Chidambaram, c...
- Action between Boehringer Ingelheim and Gennova over stroke medicine moves to courtThe approval of tenectaplase for use in stroke patients has been a point of contention between German drug maker Boehringer Ingelheim and G...
- German giant Boehringer Ingelheim battles India's Gennova Biopharma over stroke treatmentGennova recently secured marketing authorisation of tenectaplase for stroke patients in India, the first such use of the drug anywhere in t...
Load More
